Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosis

Objectives To evaluate the clinical applicability of autoantibodies (AAbs) measured by ELISA against the angiotensin II type 1 receptor (AT1R) and endothelin-1 type A receptor (ETAR) in systemic sclerosis (SSc) patients.Methods Serum samples from n=279 SSc patients from the Leiden Systemic Sclerosis...

Cijeli opis

Bibliografski detalji

Glavni autori:	Tom W J Huizinga, René E M Toes, Alexandre E Voskuyl, Gabriela Riemekasten, Saad Ahmed, Jeska K de Vries-Bouwstra, Madelon Vonk, Sophie I E Liem, Cynthia M Fehres, Eva M Hoekstra, Katherine E van der Wouden, Wieke M van Oostveen
Format:	Artigo
Jezik:	Inglês
Izdano:	BMJ Publishing Group 2025-11-01
Serija:	RMD Open
Online pristup:	https://rmdopen.bmj.com/content/11/4/e005787.full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!